AstraZeneca is reducing its sales force by cutting 1,150 jobs. These changes will account for roughly 24% of the company's sales organization in the US. The impact of the cuts will vary by geography and selling teams, the company said in a statement.
Employees will have the option to self-identify to potentially leave the company. All decisions will be finalized by early February 2012.
AstraZeneca press officer Tony Jewell declined to discuss the communication strategies related to the layoffs with PRWeek.
